The FDA has approved a personalized cellular therapy — the first of its kind — created at Penn Medicine for pediatric and young adult acute lymphoblastic leukemia (ALL).
If you are an adult with ALL between the ages of 18 and 25 years old and are interested in this CAR T cell therapy, please call 215-316-5127.
If you are calling on behalf of a child with ALL who is between the ages of 3 and 17 years old, please contact the Children's Hospital of Philadelphia (CHOP) at 267-426-0762 or Oncointake@email.chop.edu.
There are a number of ongoing clinical trials at the Abramson Cancer Center that are studying the use of CAR-T therapy in other cancers. To learn more, search our clinical trials.